Approval
Toludesvenlafaxine Wins Anxiety Approval
Luye Pharma's toludesvenlafaxine was approved in China for the treatment of generalized anxiety disorder. The approval appeared on the National Medical Products Administration website on November 19, under application numbers CXHS2600006 and CXHS2600007. The headline describes the approval as a first in nearly 20 years, without specifying the scope of that claim in the provided text.
- Drugtoludesvenlafaxine
- CompanyLuye Pharma Group
- TargetDopamine plasma membrane transport protein
- TargetNorepinephrine transporter
- TrialNCT05970510
Written by Gosset from public sources. Source types: News article. Sources are available to Gosset users. Log in to see them.